Literature DB >> 2122268

Plasma exchange as a treatment for endogenous glycosaminoglycan anticoagulant induced haemorrhage in a patient with myeloma kidney.

I R Goddard1, W K Stewart, B A Hodson, J Dawes.   

Abstract

A 57-year-old man with end-stage renal failure secondary to myeloma kidney developed haemorrhagic complications due to endogenous glycosaminoglycan anticoagulant production. Glycosaminoglycan levels and anticoagulant effect were reduced by plasma exchange and this contributed to control of the haemorrhagic manifestations.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2122268     DOI： 10.1159/000186108

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


  2 in total

1.  Treatment of Bleeding Diathesis Associated with a Heparin-Like Anticoagulant in Plasma Cell Neoplasia Using Protamine.

Authors:  Christopher A Willner; Mohammed M Chisti
Journal:  Case Rep Hematol       Date:  2018-06-13

2.  Acquired heparin-like anticoagulation process in a patient with multiple myeloma: a case report and literature review.

Authors:  Haorui Shen; Chao Wu; Lijuan Chen; Run Zhang
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.